Mounjaro after 30 days: what actually happens in the first month

You've just finished your first pen. Here is what that actually means.

Picture this: it has been four weeks, the first pen is empty, and you are wondering whether this is working. The number on the scale may have shifted a little, or it may not have moved as much as you hoped. Both are normal at this stage, and neither tells the full story.

Mounjaro (tirzepatide) works by activating two receptors involved in appetite signalling and blood-sugar regulation. The 2.5 mg dose your body has just spent a month getting used to is a tolerability dose. Its job is adjustment, not peak effect. The dose that produces the clinical trial results begins to be approached in the months that follow, as your prescriber steps you upward through the schedule. Expecting headline weight-loss figures after a single pen is a bit like judging a film by its opening credits.

What many people do notice in month one is a change in how food feels. Hunger signals arrive less insistently. Meals that once felt easy to finish start feeling complete sooner. That shift in appetite is the mechanism beginning to work, and it matters, because it is the foundation everything else is built on. You can read more about how tirzepatide works and what the wider clinical programme found on our tirzepatide overview page.

The first-month results picture: what the evidence actually shows

A question our prescribers hear most weeks is: "I've been on Mounjaro for a month and I've only lost a couple of pounds, is something wrong?" Almost always, the answer is no.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed over 2,500 adults across 72 weeks and found average weight reductions of around 20–21% at the highest dose. That figure accumulated over more than a year of treatment and escalating doses. Early weeks contribute modestly to that total; the steeper losses tend to come once the therapeutic doses are reached and sustained.

Individual variation at the 30-day mark is wide. Factors including starting weight, how strictly a reduced-calorie diet is followed, physical activity, sleep quality and metabolic history all influence early response. The clinical evidence does not suggest that a slow first month predicts a poor overall outcome. Patience at this stage is not passive, keeping consistent with the lifestyle changes your prescriber recommended alongside treatment is doing real work, even when the scale is quiet.

For context on how treatment costs fit into this longer journey, our Mounjaro cost guide for UK patients covers what a realistic multi-month course involves financially, and if you are yet to begin, our Mounjaro introductory offer sets out what is available to new patients starting their first pen.

Side effects in the first 30 days: common, manageable, and usually temporary

The first month is also when most people encounter Mounjaro's side effects, if they are going to experience them at all. The profile is led by the gastrointestinal system: nausea is the most frequently reported effect, often arriving in the day or two after an injection and then fading. Loose stools, constipation, indigestion and a general feeling of fullness that can tip into discomfort are also reported. Fatigue and mild headache feature less often.

These effects are most pronounced when treatment starts and after dose increases, the body is adjusting to a meaningful shift in how it processes food and regulates gut motility. For most people, they ease within a week or two of each new dose level. Eating smaller portions, avoiding fatty or rich foods in the first days after an injection, and staying well hydrated all help. Your Patient Information Leaflet covers the full side-effect profile in detail; the NHS tirzepatide page also sets out what to watch for and when to seek urgent help.

Rarely, more serious effects can occur. Severe or persistent stomach pain that spreads to the back (particularly alongside vomiting) should prompt same-day medical attention, as this can be a sign of pancreatitis. If you are unsure whether what you are experiencing is normal, speak to a clinician rather than waiting it out. At nume, aftercare support is available seven days a week for exactly these questions.

What happens after the first 30 days, the dose review

The end of the starter pen is the beginning of the clinical conversation, not the end of it. Before any dose increase is considered, a prescriber reviews how you have tolerated the first month: whether side effects were manageable, whether your weight has begun to shift, and whether anything in your health picture has changed. A common question at this point is whether you can use Mounjaro after 30 days, and the answer depends on that clinical review rather than the calendar alone. At nume, every repeat order goes through a fresh clinical assessment by a GPhC-registered prescriber before anything is dispensed. No automatic renewals, no skipped reviews.

If the 2.5 mg dose was well tolerated, a step to 5 mg is typically the next stage. If side effects were significant, staying at the current level for another four weeks is a common clinical decision. Both paths are legitimate. The titration schedule exists to get you to a dose that works effectively while keeping the experience manageable, rushing it rarely helps, and our guidance on taking Mounjaro after 30 days explains what that next phase looks like in practice. Our full Mounjaro guide walks through each stage of the schedule and what clinical supervision looks like throughout treatment.

If you have not yet started and are thinking about whether Mounjaro is right for you, checking your eligibility through a free consultation is the place to begin.